ON-DEMAND WEBINAR | JUL 16, 2026

Every Match Matters: Strategies for More Effective Patient Recruitment

With decades of experience across clinical planning, patient identification, and recruitment strategy, Citeline brings together data, Al, and human expertise to help sponsors find the right patients — sooner. This session covers the practical strategies and end-to-end capabilities that are making recruitment faster, more precise, and more predictable.

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

What You Will Get from This Session

  • A look at why enrollment keeps falling short — the structural, clinical, and operational barriers that prevent eligible patients from reaching the trials that could help them
  • A data-driven approach to smarter matching — how AI and RWD, including linked EMR records, claims, lab data, and clinician-reviewed algorithms, can surface protocol-matched patients earlier and more reliably than traditional methods
  • Strategies you can apply to your trial — a practical overview of how patient identification, feasibility, and patient journey insights work together across complex oncology and rare disease protocols
  • Proof it works — real-world examples showing how this approach has helped sponsors overcome recruitment roadblocks, accelerate enrollment timelines, and find the right sites in places traditional feasibility would never look
  • A clear next step — whether you are in early planning, mid-recruitment, or rethinking your strategy entirely, you’ll leave with concrete actions and an understanding of how Citeline's end-to-end recruitment capabilities can support your specific situation

Featured speakers

Headshot image of Madeline Naylor

Madeline Naylor

Chief Clinical Officer, Citeline

Dr. Naylor serves Citeline as the Chief Clinical Officer, combining her clinical and real-world data expertise to deliver the highest quality and most innovative solutions to clients and the patients they serve. She has spent 10 years managing and conducting academic and commercial research in hospitals and clinics, helping lead the largest early onset Alzheimer’s studies globally. While Madeline specializes in neurological research, she has ample experience across disease areas. She spent two years at Central Maine Cardiovascular Center, where she launched their first-ever surgical medical device trial — the Transcatheter Aortic Valve Replacement (TAVR) procedure. She has a keen interest in oncology, researching both the molecular impact and the mental health impacts of a cancer diagnosis.

Madeline is a Doctor of Health Science with a Master of Medical Science degree. She earned her Clinical Research Coordinator certification from the Association of Clinical Research Professionals.

Headshot image of Suzanne Caruso

Suzanne Caruso

President, Norstella

Suzanne Caruso is a senior business executive and clinical trial study start-up expert with over 15 years of experience in the pharmaceutical industry. As the General Manager of Clinical & Regulatory at Norstella, she leverages her expertise in artificial intelligence (AI), data analytics, and innovative trial operational models to drive efficiency for large pharma, biotech, and CRO companies. Suzanne has held roles at Veeva Systems, WCG, GSK, and Novartis and has served as a subject matter expert and adviser to over 50 organizations.